Home › Modalities › Nucleic Acid
Nucleic Acid (9 companies)
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals, Inc. | MetabolicNeurology Rare | 1 | Phase 3 | 5 |
| BEAM | Beam Therapeutics Inc. | HematologyMetabolicRespiratory Rare | 3 | Phase 1 | 8 |
| DYN | Dyne Therapeutics, Inc. | MetabolicNeurology Rare | 9 | Phase 3 | 10 |
| PHIO | Phio Pharmaceuticals Corp. | Oncology | 4 | Phase 1 | 4 |
| SRPT | Sarepta Therapeutics, Inc. | Neurology Rare | 5 | Approved | 10 |
| RARE | Ultragenyx Pharmaceutical Inc. | CardiovascularGI/HepatologyMetabolicNeurology Rare | 1 | Approved | 12 |
| VNDA | Vanda Pharmaceuticals Inc. | CardiovascularDermatologyGI/HepatologyHematologyImmunologyInfectious DiseaseNeurologyOphthalmology Rare | 2 | Approved | 26 |
| VIR | Vir Biotechnology, Inc. | Infectious DiseaseOncology Rare | 1 | Phase 3 | 10 |
| WVE | Wave Life Sciences Ltd. | MetabolicNeurologyRespiratory Rare | 5 | Phase 2 | 5 |
No companies match.